These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27091400)

  • 1. Optimized dissociation protocol for isolating human glioma stem cells from tumorspheres via fluorescence-activated cell sorting.
    Lv D; Ma QH; Duan JJ; Wu HB; Zhao XL; Yu SC; Bian XW
    Cancer Lett; 2016 Jul; 377(1):105-15. PubMed ID: 27091400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of Glioblastoma Stem Cells with Flow Cytometry.
    Inocencio J; Frenster JD; Placantonakis DG
    Methods Mol Biol; 2018; 1741():71-79. PubMed ID: 29392691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized flow cytometric analysis of central nervous system tissue reveals novel functional relationships among cells expressing CD133, CD15, and CD24.
    Panchision DM; Chen HL; Pistollato F; Papini D; Ni HT; Hawley TS
    Stem Cells; 2007 Jun; 25(6):1560-70. PubMed ID: 17332513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limits of CD133 as a marker of glioma self-renewing cells.
    Clément V; Dutoit V; Marino D; Dietrich PY; Radovanovic I
    Int J Cancer; 2009 Jul; 125(1):244-8. PubMed ID: 19350631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma.
    Yuan Y; Yan Z; Miao J; Cai R; Zhang M; Wang Y; Wang L; Dang W; Wang D; Xiang D; Wang Y; Zhang P; Cui Y; Bian X; Ma Q
    Stem Cell Res Ther; 2019 Nov; 10(1):330. PubMed ID: 31747975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cell dissociation on identification of breast cancer stem cells.
    Quan Y; Yan Y; Wang X; Fu Q; Wang W; Wu J; Yang G; Ren J; Wang Y
    Cancer Biomark; 2012-2013; 12(3):125-33. PubMed ID: 23481571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface Nestin is a biomarker for glioma stem cells.
    Jin X; Jin X; Jung JE; Beck S; Kim H
    Biochem Biophys Res Commun; 2013 Apr; 433(4):496-501. PubMed ID: 23524267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
    Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
    Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel imaging agent using peptide-coated gold nanoparticles toward brain glioma stem cell marker CD133.
    Cho JH; Kim AR; Kim SH; Lee SJ; Chung H; Yoon MY
    Acta Biomater; 2017 Jan; 47():182-192. PubMed ID: 27721007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
    Srivastava VK; Nalbantoglu J
    Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Development and Applications of a Dual Optical Imaging System for Studying Glioma Stem Cells.
    Tai PA; Liu YL; Wen YT; Lin CM; Huynh TT; Hsiao M; Wu ATH; Wei L
    Mol Imaging; 2019; 18():1536012119870899. PubMed ID: 31478435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.
    Hu PS; Xia QS; Wu F; Li DK; Qi YJ; Hu Y; Wei ZZ; Li SS; Tian NY; Wei QF; Shen LJ; Yin B; Jiang T; Yuan JG; Qiang BQ; Han W; Peng XZ
    Oncogene; 2017 Aug; 36(33):4706-4718. PubMed ID: 28394339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
    Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of connexin30 on the stemness of glioma: connexin30 reverses the malignant phenotype of glioma by modulating IGF-1R, CD133 and cMyc.
    Arun S; Ravisankar S; Vanisree AJ
    J Neurooncol; 2017 Dec; 135(3):473-485. PubMed ID: 28875331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.
    Choi SA; Wang KC; Phi JH; Lee JY; Park CK; Park SH; Kim SK
    Cancer Lett; 2012 Nov; 324(2):221-30. PubMed ID: 22652175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.
    Dzaye O; Hu F; Derkow K; Haage V; Euskirchen P; Harms C; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
    J Neuropathol Exp Neurol; 2016 May; 75(5):429-40. PubMed ID: 27030742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.